Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study

AIM: To evaluate the combination of bevacizumab with infusional 5-fluorouracil (5-FU), leucovorin (LV) and irinotecan (FOLFIRI) in patients with advanced colorectal cancer (CRC) pretreated with combination regimens including irinotecan and oxaliplatin. METHODS: Fourteen patients (median age 56 years...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kwon, Hyuk-Chan, Oh, Sung Yong, Lee, Suee, Kim, Sung-Hyun, Kim, Hyo-Jin
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2007
Предметы:
Rapid Communication
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171235/
https://ncbi.nlm.nih.gov/pubmed/18069765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i46.6231
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы